Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec;72(12):6932-8.
doi: 10.1128/IAI.72.12.6932-6938.2004.

Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia

Affiliations

Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia

Craig S Boutlis et al. Infect Immun. 2004 Dec.

Abstract

Individuals in areas of intense malaria transmission exhibit resistance (or tolerance) to levels of parasitemia in their blood that would normally be associated with febrile illness in malaria-naive subjects. The resulting level of parasitemia associated with illness (the pyrogenic threshold) is highest in childhood and lowest in adulthood. Clinical parallels between malarial and bacterial endotoxin tolerance have led to the supposition that both share common physiological processes, with nitric oxide (NO) proposed as a candidate mediator. The hypotheses that NO mediates tolerance and blood stage parasite killing in vivo were tested by determining its relationship to age and parasitemia cross-sectionally and longitudinally in a population of 195 children and adults from Papua New Guinea encountering intense malaria exposure. Despite pharmacological clearance of asymptomatic parasitemia, NO production and mononuclear cell NO synthase (NOS) activity were remarkably stable within individuals over time, were not influenced by parasitemia, and varied little with age. These results contrast with previous smaller cross-sectional studies. Baseline NO production and NOS activity did not protect against recurrent parasitemia, consistent with previous data suggesting that NO does not have antiparasitic effects against blood stage infection in vivo. The NO indices studied were markedly higher in specimens from study subjects than in samples from Australian controls, and NOS activity was significantly associated with plasma immunoglobulin E levels, consistent with induction of NO by chronic exposure to other infections and/or host genetic factors. These results suggest that NO is unlikely to mediate killing of blood stage parasites in this setting and is unlikely to be the primary mediator in the acquisition or maintenance of malarial tolerance.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
A. Blood smear results in 424 subjects from Papua New Guinea who were screened for enrollment into the study. Results represent the reading of a single daily smear. (B) Parasite density of P. falciparum in 105 enrolled subjects at baseline. Diamonds signify the higher of two measurements taken 24 h apart.
FIG. 2.
FIG. 2.
Plasma NOx levels in Darwin controls (DC) and PNG subjects not excluded at T0. The median plasma NOx level in Darwin controls (11 μmol/liter; IQR, 7 to 24) was significantly lower than for each age group of PNG subjects (P < 0.001 for each pairwise comparison; Mann-Whitney U test). In the PNG group, age only explained 2.5% of the overall variation in plasma NOx levels (P = 0.033), with the predicted NOx level falling 3.5% for every 5 years of increasing age. The horizontal lines in the middle of the boxes represents the median, and the boxes extend from the 25th to the 75th percentile. Whiskers extend no further than the most distant data point or 1.5 times the IQR. Outlying values are represented by dots.

Similar articles

Cited by

References

    1. Anstey, N. M., C. S. Boutlis, and J. R. Saunders. 2002. Systemic nitric oxide production in human malaria. I. Analysis of NO metabolites in biological fluids. Methods Mol. Med. 72:461-467. - PubMed
    1. Anstey, N. M., J. B. Weinberg, M. Y. Hassanali, E. D. Mwaikambo, D. Manyenga, M. A. Misukonis, D. R. Arnelle, D. Hollis, M. I. McDonald, and D. L. Granger. 1996. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184:557-567. - PMC - PubMed
    1. Anstey, N. M., J. B. Weinberg, Z. Wang, E. D. Mwaikambo, P. E. Duffy, and D. L. Granger. 1999. Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children. Am. J. Trop. Med. Hyg. 61:253-258. - PubMed
    1. Anstey, N., J. Weinberg, and D. Granger. 1999. Nitric oxide and malaria, p. 311-341. In F. C. Fang (ed.), Nitric oxide and infection. Plenum Publishing Corp, New York, N.Y.
    1. Applegarth, D. A., and P. M. Ross. 1975. The unsuitability of creatinine excretion as a basis for assessing the excretion of other metabolites by infants and children. Clin. Chim. Acta 64:83-85. - PubMed

Publication types

MeSH terms